Faculty

Dr. Frank Arko is currently Chief of Endovascular Surgery and Co-director of the Aortic Institute at Atrium Health, Sanger Heart and Vascular Institute in Charlotte, NC.  

Dr. Arko earned his Bachelor of Science (summa cum laude) and his medical degree with (with honors) at Texas A&M University. He completed his internship and his residency at Scott & White Hospital, Texas A&M University Health Science Center in 1999. Dr. Arko completed his Clinical Vascular Fellowship in 2000 and his Endovascular Fellowship in 2001 at Stanford University Hospital in California. He completed a Post-Doctoral Research Fellowship at Stanford University Hospital in 2001.  

Dr. Arko is a member of numerous surgical societies including: The Southern Association for Vascular Surgery, International Academy of Clinical and Applied Thrombosis/Homeostasis, Society for Vascular Surgery, International Society of Endovascular Specialists, Peripheral Vascular Surgery Society and American College of Surgeons. 

Dr. Arko has authored 15 book chapters and has more than 140 articles published in peer-reviewed medical journals including the Journal of Vascular Surgery, Journal of Endovascular Therapy, and the Annals of Thoracic Surgery.    

Dr. Arko is part of one of the largest practices in the US for complex aortic reconstructions with placement of first-in-man graft for complex aortic arch aneurysms. 

Julie J. Berumen is a Critical Care Registered Nurse and is the Critical Limb Ischemia Navigator at the Hospitals of Providence at Memorial in El Paso, Texas. In her role, she is responsible for the care coordination of patients with peripheral artery disease, working with a multidisciplinary team of health care providers. She is also in charge of organizing staff and patient education, along with quality care improvement and risk management.

Julie earned her Bachelor of Science in Nursing from the University of Texas in El Paso and completed her Master of Science in Nursing with an emphasis in Quality and Risk Management in Phoenix, Arizona.

She has given presentations on permanent pacemakers, the risk of elevated A1Cs in relation to Peripheral Artery Disease, and 12-lead EKGs. She is a member of The American Association of Critical Care Nurses, The American Nursing Association and Texas Nursing Association, National Association for Healthcare Quality, and CLI Global Society, as well as a past president of the Paso del Norte Chapter of The American Association of Critical Care Nurses.

Dr. Stephen Black is a Consultant Vascular Surgeon at Guy’s and St. Thomas’ Hospital and a Professor of Venous Surgery at Kings College, London. Dr. Black is the Clinical Lead for Vascular Surgery at Guy’s and St. Thomas’ Hospital and the Co-R&D Lead for the Cardiovascular Directorate (Cardiology, Cardio-Thoracic and Vascular Surgery).

Dr. Black is the Co-founder & Medical Director at the UK Vein Clinic. In Private Practice, he undertakes medical consultations and minimally invasive procedures, and his principal clinical interest is the treatment of Venous Disease. Dr. Black has established a large practice in the treatment of both Acute and Chronic Deep Venous Disease as well as superficial venous disorders and together with a comprehensive multi-disciplinary team of colleagues at Guy's and St Thomas' Hospital, he is part of one of the largest such services in Europe.

Following his medical training in South Africa at the University of the Witwatersrand, Dr. Black completed his MD degree at St. Mary’s Hospital and Imperial College (London) in 2006 under the supervision of Mr. John Wolfe and Lord Ara Darzi. In 2011, Dr. Black received the fellowship of the European Board of Vascular Surgery.

Dr. Black is the Program Director for both the European Venous Forum Hands-On Workshops and the Charing Cross Vascular Symposium Venous Programme. Dr. Black was the Venous Tutor for the European Society of Vascular Surgery from 2014-2018 and is an examiner for the Fellowship of the European Board of Vascular Surgery.

Dr. Black has lectured and published extensively on the subjects of treatment of acute and chronic DVT as well as the treatment of superficial venous disease, in addition to other areas of vascular surgery and education. He is currently the Editor in Chief for Vascular and Endovascular Review and serves on the Editorial Board for International Angiology.

In addition, Dr. Black is the global and UK principal investigator for a number of ongoing trials, and is actively involved in research to improve the treatment of patients with Venous Disease and has been involved a number of first-in-man procedures.

Dr. Kush Desai is an Interventional Radiologist and Associate Professor of Radiology, Surgery, and Medicine at the Northwestern University Feinberg School of Medicine. His primary research and clinical interests are in venous thromboembolic disease, deep venous thrombectomy/thrombolysis, reconstruction of chronic venous occlusions, IVC filter management/complex IVC filter retrieval, and interventional pulmonary embolism management.

Dr. Desai serves as the chair of the Society of Interventional Radiology’s venous clinical specialty council, and is a fellow of the society. He serves as the national and global principal investigator for numerous clinical trials that are developing strategies and devices to treat deep venous disease. In addition, he serves as a reviewer for several journals, including Circulation, and the Journal of the American College of Cardiology, as a distinguished reviewer for Journal of Vascular Surgery: Venous and Lymphatic Disorders, and as a top reviewer for Journal of Vascular and Interventional Radiology.

With more than two decades of experience, triple board-certified Interventional Cardiologist Dr. Andrey Espinoza has amassed many accolades. A repeat New Jersey Monthly Top Doctor, he is also a manuscript reviewer for the Journal of Cardiac Catheterization and Intervention and served on an investigational team that led to approval of a breakthrough stent technology to replace permanent metallic implants.

When it comes to assessing his accomplishments, however, Dr. Espinoza insists there’s only one metric that matters. “I gauge my success,” he says, “by the embraces I receive from my patients.”

It’s no wonder then that when he founded the Advanced Heart and Vascular Institute of Hunterdon, Dr. Espinoza sought to create a compassionate, patient-oriented practice that leverages his expertise in cardiovascular medicine, endovascular medicine and interventional cardiology, as well as his keen interest in cardiovascular genetics, cardio-oncology and sports cardiology.

Always striving to bring his patients the most innovative cardiac techniques, Dr. Espinoza—a member of the American College of Cardiology’s Peripheral Vascular Disease Section and the Society of Cardiovascular Angiography and Intervention’s Carotid Committee and Vascular Disease Council—was also involved in an international clinical trial leading to the approval of a PCSK9 inhibitor for lowering cholesterol in heart disease patients.

Dr. Fabrizio Fanelli is a Professor of Radiology and the Director of the Vascular and Interventional Radiology Department at Careggi University Hospital, University of Florence. Dr. Fanelli is certified by the European Board of Interventional Radiology (EBIR).

An active researcher, Dr. Fanelli has participated in more than 20 clinical research studies and has authored or co-authored more than 100 scientific publications in peer-reviewed journals. Dr. Fanelli has also authored 4 books and co-authored 19 books on radiological-interventional sciences and has been an invited speaker at more than 400 international congresses.

Dr. Fanelli has been involved in more than 90 training courses on endovascular techniques, serving as organizer and co-organizer of several international and national courses.

Dr. Fanelli is an active member of the Italian Society of Medical and Interventional Radiology (SIRM), European Society of Radiology (ESR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Society of Interventional Radiology (SIR), and the Italian College of Interventional Radiology (ICIR).

He currently serves as a member of the program committee of Interdisciplinary Endovascular Aortic Symposium (IDEAS) and is responsible for the organization of CIRSE’s “PAD Day” Symposium. Dr. Fanelli is also an editor for EURORAD, a publication of the Vascular and Interventional Radiology section of ESR, and an Associate Editor of JVIR and CVIR Endovascular and Diagnostics. He also serves on the editorial board and as a reviewer for several other medical journals.

Dr. Raghu Kolluri is the President of the Society for Vascular Medicine. He serves as the Medical Director of Syntropic Core Lab at OhioHealth Research and Innovation Institute. As the System Medical Director of Vascular Medicine at OhioHealth, he directs the Vascular Medicine service line and Vascular Laboratories across 12 hospitals in central Ohio.  

A graduate of the Armed Forces Medical College, India, Dr. Kolluri earned his Master of Science degree in Physiology from Penn State University, and received Internal Medicine residency training at Riverside Methodist Hospital in Columbus, Ohio, followed by Vascular Medicine fellowship training at the Cleveland Clinic.  

A well-known vascular educator, Dr. Kolluri has been invited to organize and lecture at several cardiovascular conferences across the world. He co-founded The VEINS meeting in 2011, and also founded the SVM Fellows and SVM Advanced Practice Provider review courses. 

Dr. Kolluri serves as a reviewer for several cardiovascular journals and serves on the editorial board for journals Vascular Medicine and Annals of Vascular Surgery. His clinical and research interests include non-invasive testing, peripheral artery disease, deep venous thrombosis, critical limb ischemia, and chronic venous disease. 

Dr. Prakash Krishnan is an expert in peripheral vascular disease and is internationally recognized as a leader in the catheter-based treatment of coronary artery disease and peripheral arterial disease. Dr. Krishnan’s expertise includes nonsurgical treatment of coronary and peripheral vascular diseases including coronary stents, peripheral vascular angioplasty and stents, atherectomy, carotid stents, renal stents, renal denervation and complex venous disease intervention.

Dr. Krishnan is the System Director of Endovascular Services at the Mount Sinai Health System and Director of the Endovascular Intervention Fellowship in the Cardiac Catheterization Laboratory.

Dr. Krishnan was the Co-National Primary Investigator in the ILLUMENATE Trial, a multicenter randomized control study evaluating the safety and efficacy of the Stellarex drug-coated balloon in femoropopliteal lesions. He has received numerous awards and honors. He has authored numerous peer-reviewed articles and book chapters on peripheral arterial disease and is the Director of the NY Endovascular Summit, formerly LINC Mount Sinai Endovascular Symposium, an Icahn School of Medicine at Mount Sinai and Cardiovascular Institute-supported program, and Director of Mount Sinai’s Live Peripheral Interventions webcast series.

Dr. Steven Kum is a Vascular, Endovascular and General Surgeon at Mount Elizabeth Novena Hospital and Changi General Hospital, Singapore.

Dr. Kum received his medical degree from the National University of Singapore in 2000 and subsequently embarked on his surgical training with the Royal College of Surgeons, obtaining his Master of Medicine and Fellowship in 2007.

In 2009, Dr. Kum completed his postgraduate fellowship in Vascular and Endovascular Surgery at the Prince of Wales Hospital, Sydney as well as at the Department of Angiology at the Leipzig Heart Center. In 2012, he completed a second fellowship on advanced techniques in diabetic limb salvage and wound care techniques at the Universita Vita Salute San Raffaele, Milan.

Since 2015, Dr. Kum has been the Director of Vascular Surgery in the Department of Surgery at Changi General Hospital and he was subsequently appointed as a visiting consultant in 2019.

A clinical lecturer in both the NUS Yong Loo Lin School of Medicine and Lee Kong Chian School of Medicine in Singapore, Dr. Kum also serves as a faculty member for general surgical residents for SingHealth.

Dr. Kum regularly proctors physicians in endovascular procedures in Europe and Asia. He is frequently invited to several regional and international meetings and is part of the organizing committee of LINC and VERVE.

Dr. Kum has a keen interest in clinical research revolving around diabetic limb salvage. He is proficient in percutaneous deep arterialization for no-option critical limb ischemia, on which he has authored or co-authored numerous papers.

Dr. Kum is the principal investigator or co-PI for several industry- and physician-led studies, and is a keen innovator who is currently working on several revolutionary technologies.

Dr. Nicos Labropoulos is a professor of Surgery and Radiology and the Director of the Vascular Laboratory at Stony Brook University Hospital in Long Island, NY.

Dr. Labropoulos completed his undergraduate training at the University of London and his PhD and Vascular Fellowship at St. Mary’s Hospital, Imperial College of Science Technology and Medicine, London, UK.

Dr. Labropoulos has been awarded multiple grants for clinical and basic science studies, many prizes in medical and surgical meetings around the world and has been a traveling fellow of the Royal Society of Medicine.

He is actively involved in many national and international vascular and venous societies as well as national committees and accrediting organizations. He serves on the editorial board of 11 journals and is a reviewer for over 20 medical and surgical journals. He has more than 300 publications, has been cited over 15000 times and has given over 1200 presentations around the world. He has edited 5 vascular textbooks and has contributed over 60 book chapters on the diagnosis and management of vascular diseases.

He has been working on vascular imaging, aortic wall remodeling, cerebrovascular disease, and the development and natural history of chronic venous disorders and venous thromboembolism including the inflammatory pathways in both. He served on the Panel of VTE Experts at the Joint Commission and the National Quality Forum and is a recipient of the Society of Vascular Surgery’s Presidential Citation Award and UIP Gold Medal award of excellence for clinical research in Phlebology. He is also actively involved in vascular training and education through many local, national, and international organizations and has organized numerous vascular meetings. Dr. Labropoulos is a co-founder of the International Vascular Foundation, the Institute of Vascular Diseases, and the Venous Health Foundation.

Dr. Marco Manzi is an Interventional Radiologist practicing in Abano Terme, Italy. Dr. Manzi earned his medical degree at the University of Milan, and after serving as an Army Medical Officer, he completed Radiology training at Boldrini Hospital, Vicenza and at the Radiology Institute at the University of Ferrara.

Dr. Manzi then joined the Radiology Institute at San Bartolo Hospital, Vicenza, where he served as Director of the International Radiology Unit from 1999 until he assumed his current position in 2007.

An active industry proctor, Dr. Manzi has been involved in teaching distal revascularization technical courses for many years.

Dr. Manzi has authored more than 50 publications in peer-reviewed medical journals and has been an invited faculty member at leading medical congresses and courses in Europe and the United States. These include: Cardiovascular and Interventional Society of Europe (CIRSE), LINC, Charing Cross, VEITH, VIVA, Cleveland Clinic, NCVH, PAIRS, EuroPCR, ASVS, Encore Seoul , JET, CCT Japan, APSCVIR and more.

Dr. Manzi is member of CIRSE, the Interventional Radiology Section of the SIRM (Italian Society of Medical Radiology), the Italian-European Society of Interventional Radiology (IESIR), the European Society of Radiology (ESIR), and is an honorary member of the Interventional Radiology Society of Australasia (IRSA).

Dr. Manzi’s clinical interests include vascular imaging, atherosclerotic vascular diseases, atherectomy, endovascular procedures, PAD, CLI, arterial occlusive diseases, and limb salvage.

Dr. Jason Mendivil is a native El Pasoan and graduated from Americas High School in 2002. He attended Trinity University for his undergraduate degree and went on to obtain his Doctor of Podiatric Medicine (DPM) degree from Barry University in Miami Shores, Florida in 2013.
Dr. Mendivil completed a three-year foot and ankle and reconstructive rearfoot surgery residency training at Southern Arizona Veterans Affairs Healthcare System in Tucson, where he worked closely with an amputation prevention and limb salvage team.

Dr. Mendivil has extensive training and experience in limb salvage surgery and advanced wound management, including diabetic foot wounds and reconstructive surgery. He has become well known as a limb salvage expert and continues to advance the field of podiatry through research and development of new treatments. He is a leader in his field, using advanced treatments for wound healing, such as autogenous stem cell therapy and platelet-rich plasma for advanced wound management.

Dr. Mendivil is experienced in performing the most advanced foot and ankle reconstructive surgical procedures available for limb preservation and amputation prevention. He serves on the Editorial Board for Ostomy Wound Management (OWM) and is a member of the American College of Foot and Ankle Surgeons, American Podiatric Medical Association, and the American Academy of Podiatric Sports Medicine. He is also one of the founders of PULSE Amputation Prevention Centers, currently serving as the Director of Surgery and Wound Care.

Dr. Erin H. Murphy is a vascular surgeon with the Sanger Heart and Vascular Institute at Atrium Health in Charlotte, NC, where she serves as the Director of the Venous and Lymphatic Program. She specializes in the treatment of pelvic and lower extremity venous disorders.

Dr. Murphy is dedicated to both her patients as well as the advancement of the venous field. She has extensive research experience and has authored over 50 medical journal articles, book chapters and editorials. She presents routinely at both national and international conferences. She is currently participating in several major venous trials and is the US principal investigator for the Medtronic ABRE stent trial.

Dr. Sahil A. Parikh is the Director of Endovascular Services at Columbia University Medical Center and an Assistant Professor of Medicine at the Columbia University College of Physicians and Surgeons.

Dr. Parikh graduated magna cum laude from Harvard College with an AB in Biomedical Sciences and Engineering and went on to earn his MD from the Johns Hopkins University School of Medicine with Phi Beta Kappa and Alpha Omega Alpha honors. He completed his internal medicine residency and chief residency at Massachusetts General Hospital, cardiovascular medicine and interventional cardiology fellowships at Brigham and Women’s Hospital and vascular medicine and interventional fellowships at Massachusetts General Hospital, all teaching hospitals affiliated with Harvard Medical School. He is board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Vascular Medicine and Endovascular Intervention.

Dr. Parikh’s clinical practice leverages his knowledge and experience in cardiovascular medicine and complex coronary and peripheral vascular interventions, with a focus on atherosclerotic vascular disease and intervention throughout the circulation. This includes coronary artery disease, PAD including claudication and CLI, renovascular disease, cerebrovascular disease, venous disease and thrombosis. He is a nationally recognized clinician educator and investigator in vascular medicine and intervention.

Dr. Parikh has won numerous teaching awards locally and co-directs several national educational programs for physicians in training and for continuing medical education in conjunction with the Cardiovascular Research Foundation (CRF), the American College of Cardiology (ACC) and the Society for Cardiac Angiography and Intervention (SCAI). His research interests focus on novel endovascular devices for the treatment of vascular disease. He has been the site and national principal investigator for several clinical trials and has authored more than 100 original manuscripts and reviews in basic and clinical cardiovascular medicine. He lectures frequently at national meetings including the Transcatheter Cardiovascular Therapeutics (TCT), ACC and SCAI.

Dr. Laiq Raja is an Interventional Cardiologist practicing in El Paso, Texas. Dr. Raja earned his medical degree at the Autonomous University of Cuidad Juárez in Mexico and did his Residency in Internal Medicine at the Texas Tech University Health Sciences Center in El Paso.

Dr. Raja furthered his training, completing fellowships in Cardiovascular Diseases and Interventional Cardiology at the University of Texas Health Sciences Center in San Antonio, and he is an Assistant Professor at Texas Tech University Health Sciences Center in El Paso.

Board-certified by the American Board of Vascular Medicine, the American Board of Interventional Cardiology, the American Board of Cardiology & CV Diseases, the American Board of Internal Medicine, and the Certification Board of Nuclear Cardiology, Dr. Raja has served as principal investigator in numerous clinical research studies and has published in journals including Endovascular Today and Cath Lab Digest.

Since 2018, Dr. Raja has served as Director and President of PULSE Amputation Centers, and he is also the Director of Cardiology and Medical Director of the CLI Program at The Hospitals of Providence (Memorial Campus). To help ensure the best possible care and improved quality of life for all patients, Dr. Raja has trained over 300 physicians nationwide across all vascular specialties.

Dr. Fadi A. Saab is an Interventional Cardiologist specializing in endovascular revascularization of peripheral vascular disease. A leader in critical limb ischemia (CLI), he also specializes in treating varicose veins and cardiac issues, including high blood pressure and carotid artery disease.

Board-certified in Internal Medicine, with subspecialty certification in Cardiology and Interventional Cardiology, Dr. Saab holds additional certification in Cardiovascular Medicine, Nuclear Cardiology, and Echocardiography. Dr. Saab also serves as a Clinical Associate Professor of Medicine at the Michigan State University College of Human Medicine.

Dr. Saab earned his medical degree from the Damascus University School of Medicine in Syria and completed his Internal Medicine residency at Detroit Medical Center-Sinai Grace Hospital in Detroit, Michigan. He then completed a Cardiology Outcome research fellowship at the University of Michigan in Ann Arbor; a Noninvasive Cardiology fellowship at St. John Hospital & Medical Center in Detroit; and fellowships in Cardiovascular Medicine and Interventional Cardiology at Baystate Medical Center (Tufts School of Medicine), in Springfield, MA.

In 2017, Dr. Saab co-founded the Advanced Cardiac and Vascular Amputation Prevention Centers, envisioning a nationwide network for patients seeking specialized cardiac care and alternatives to limb amputation.

Dr. Saab has participated in more than 15 clinical research studies, has authored more than 25 peer-reviewed publications, and has been an invited speaker at regional, national, and international conferences. In addition, he is Co-Director of the AMPutation Prevention Symposium, an international conference focusing on CLI therapy.

A fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography, Dr. Saab is also a member of the Critical Limb Ischemia Global Society.

Dr. Mike Watts is an interventional radiologist dedicated to providing the highest level of service through clinical excellence and a commitment to patient and family centered care.

Dr. Watts graduated from Colgate University in 2002 with a major in Chemistry. He earned his medical degree at the University of Buffalo in 2006, completed his surgical internship and radiology residency at the Cleveland Clinic in 2011, and a fellowship at the University of Pennsylvania in 2012.

Dr. Watts specializes in advanced peripheral arterial disease techniques, minimally invasive cancer treatments, venous disease, and management of portal hypertension. He has been invited to speak on these topics at multiple regional, national, and international conferences.

Committed to education, he served as the Interventional Radiology Fellowship Director at the University of Pennsylvania and created one of the first Interventional Radiology residencies in the United States. His devotion to hands-on teaching of complex techniques has driven him to continuous improvement through a commitment to lifelong learning and innovation of novel procedural techniques.

Since 2016, he has been committed to limb preservation, treating CLI on a full-time basis using advanced and innovative techniques to bring unsurpassed quality of care to patients throughout Eastern Pennsylvania and New Jersey.

Dr. Bret Wiechmann has been in private practice for 24 years with Vascular & Interventional Physicians, with a particular interest in peripheral arterial disease and critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow by the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS).

Dr. Wiechmann has given over 190 invited lectures and has been principal investigator for numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is currently President-elect. Dr. Wiechmann’s practice includes six interventional radiologists and has been involved with the treatment of arterial and venous disorders for a number of years, both hospital-based and at the office-based lab, which opened in 2006.

Dr. Bryan T. Fisher is both an expert in limb preservation and a nationally recognized vascular surgeon at Tri-Star Centennial Medical Center in Nashville, Tennessee. Uniquely qualified to address the challenges and solutions aimed at the delivery of high-quality patient care, Dr. Fisher is consistently recognized by his peers as a caring professional and respected colleague in the Nashville community.

Dr. Fisher graduated with honors from Tennessee State University and became a Ronald McNair and MARC Scholar. He was accepted into the UW Madison School of Medicine and Public Health, but deferred one year to teach elementary school in an underserved Virginia community. After medical school, Dr. Fisher completed a five-year general surgery residency at The Ohio State University under Dr. E. Christopher Ellison. He then culminated his surgical training at Vanderbilt University under Dr. Thomas C. Naslund.

Board-certified in Vascular Surgery, Dr. Fisher serves as the Chief of Vascular Surgery, Director of Wound Care, and co-Director of the Center for Limb Preservation HCA Healthcare's Centennial Medical Center, and is a member of The Surgical Clinic in Nashville. As Chief of Vascular Surgery at Tri-Star Centennial’s Heart and Vascular Center, Dr. Fisher provides his leadership and vision of providing cutting-edge, personalized, high quality care for patients with vascular disease.

Dr. Fisher specializes in complex open, endovascular and hybrid techniques in the treatment of aortic disease and lower extremity occlusive disease. Under Dr. Fisher's leadership, Tri-Star Centennial Medical Center has become a national leader in providing a multidisciplinary approach to vascular disease.

Lorena C. Henderson is a Family Nurse Practitioner and the Administrator and Clinical Director of the Amputation Prevention and Patient Care Coordination Program at PULSE, a novel multidisciplinary program focused on wound and vascular management and limb preservation.

She also serves as Clinical Research Coordinator for El Paso Cardiology Associates, under the direction of Dr. Laiq Raja, MD.

Lorena earned her Bachelors of Science in Nursing at the University of Texas at El Paso and completed her Masters of Science in Nursing as a Certified Family Nurse Practitioner at the Texas Tech University Health Sciences Center School of Nursing in Lubbock, Texas.

Credentialed at all of the Hospitals of Providence (Sierra, Memorial and Transmountain) and Las Palmas Medical Center in El Paso, Lorena practices under the specialty of cardiology. She has focused specialization in the treatment and management of critical limb ischemia and amputation prevention under the direct supervision of Dr. Laiq Raja, MD, one of the country’s foremost experts in the treatment of critical limb ischemia, who is the director of the Amputation Prevention Program at the Hospitals of Providence as well as PULSE Amputation Prevention Centers.

A published author in Cath Lab Digest and Endovascular Today, Lorena has assisted in the development and initiation of a CLI and Amputation Prevention Treatment Program in collaboration with a local healthcare system as well as being a co-founder of PULSE Amputation Prevention Centers. Early in her career she was also involved in the development of heart failure program initiatives to establish dedicated heart failure clinics. Lorena is a member of the Sigma Theta Tau International Honor Society of Nursing.